Trial intelligence / Profile preview

Anastrozole vs Clomiphene in Male Hypogonadism

NCT03933618Phase 2Completed

Sponsor
Albany Medical College
Start
Apr 2015
Primary completion
Mar 2017
Modality
Irreversible Covalent Inhibitors, Orthosteric Ligands
01

Overview

Phase 2, randomised, double-blind trial of anastrozole and clomiphene in male hypogonadism (6 arms), sponsored by Albany Medical College. Primary endpoint: International Index of Erectile Function at Week 24. Started Apr 2015; status: completed.

02

Drugs

anastrozoleclomiphene
03

Conditions

male hypogonadism

Beyond the preview

Go deeper on NCT03933618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03933618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call